AXQ Capital LP acquired a new stake in shares of Dolby Laboratories (NYSE:DLB – Free Report) during the 4th quarter, Holdings Channel.com reports. The institutional investor acquired 11,388 shares of the electronics maker’s stock, valued at approximately $731,000.
Several other institutional investors have also recently modified their holdings of the company. Boothbay Fund Management LLC increased its position in shares of Dolby Laboratories by 4.1% in the 2nd quarter. Boothbay Fund Management LLC now owns 4,020 shares of the electronics maker’s stock valued at $299,000 after acquiring an additional 157 shares during the period. Covestor Ltd increased its position in shares of Dolby Laboratories by 6.0% in the 4th quarter. Covestor Ltd now owns 3,088 shares of the electronics maker’s stock valued at $198,000 after acquiring an additional 175 shares during the period. Fifth Third Bancorp increased its position in shares of Dolby Laboratories by 34.7% in the 4th quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker’s stock valued at $48,000 after acquiring an additional 192 shares during the period. Gabelli Funds LLC increased its position in shares of Dolby Laboratories by 0.4% in the 3rd quarter. Gabelli Funds LLC now owns 49,143 shares of the electronics maker’s stock valued at $3,556,000 after acquiring an additional 202 shares during the period. Finally, Hantz Financial Services Inc. increased its position in shares of Dolby Laboratories by 166.7% in the 3rd quarter. Hantz Financial Services Inc. now owns 352 shares of the electronics maker’s stock valued at $25,000 after acquiring an additional 220 shares during the period. 58.56% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
DLB has been the topic of several research reports. Barrington Research reissued an “outperform” rating and issued a $90.00 target price on shares of Dolby Laboratories in a research report on Monday, April 27th. Weiss Ratings reissued a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Friday, March 27th. Finally, Wall Street Zen raised Dolby Laboratories from a “hold” rating to a “buy” rating in a research report on Saturday. Three investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $90.75.
Insider Activity
In other news, SVP John D. Couling sold 7,666 shares of the stock in a transaction dated Tuesday, May 5th. The shares were sold at an average price of $57.55, for a total transaction of $441,178.30. Following the sale, the senior vice president directly owned 118,353 shares of the company’s stock, valued at $6,811,215.15. This represents a 6.08% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Robert J. Park sold 4,895 shares of the stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $56.68, for a total transaction of $277,448.60. Following the sale, the chief financial officer directly owned 81,490 shares in the company, valued at approximately $4,618,853.20. The trade was a 5.67% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 32,125 shares of company stock valued at $1,805,270. Insiders own 37.93% of the company’s stock.
Dolby Laboratories Stock Performance
Shares of DLB opened at $55.63 on Wednesday. The business’s 50-day moving average is $59.35 and its two-hundred day moving average is $62.93. The company has a market capitalization of $5.26 billion, a P/E ratio of 21.99 and a beta of 0.81. Dolby Laboratories has a fifty-two week low of $52.45 and a fifty-two week high of $77.00.
Dolby Laboratories (NYSE:DLB – Get Free Report) last posted its earnings results on Thursday, April 30th. The electronics maker reported $1.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.31 by $0.06. Dolby Laboratories had a net margin of 17.85% and a return on equity of 11.47%. The business had revenue of $395.63 million for the quarter, compared to analyst estimates of $385.80 million. During the same period in the prior year, the company posted $1.34 EPS. The company’s revenue for the quarter was up 7.0% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. Analysts forecast that Dolby Laboratories will post 3.21 EPS for the current year.
Dolby Laboratories Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Wednesday, May 20th. Stockholders of record on Tuesday, May 12th were paid a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a dividend yield of 2.6%. The ex-dividend date of this dividend was Tuesday, May 12th. Dolby Laboratories’s dividend payout ratio is presently 56.92%.
Dolby Laboratories Company Profile
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Read More
- Five stocks we like better than Dolby Laboratories
- Marvell Stock Soars on NVIDIA’s Trillion-Dollar Nod
- FirstCash Turns Pawn Into a Growth Machine
- HubSpot Just Crushed the Bear CaseāIs a Bigger Rally Ahead?
- Aggressive Insider Buying Signals Opportunity in 3 Risky Stocks
Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB – Free Report).
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
